비교리스트

 카트 문의
시장보고서
상품코드
1293845

바이오액티브 창상 치료 시장 : 성장, 미래 전망, 경쟁 분석(2023-2031년)

Bioactive Wound Care Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 115 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오액티브 창상 치료 시장은 2031년까지 7.5% 성장할 것으로 예상됩니다. 기존 창상 치료는 깊은 절상, 화상, 만성 궤양과 같은 급성 창상 치료에 비생산적인 것으로 밝혀졌습니다. 바이오액티브 창상 치료 제품의 도입은 이러한 심각한 창상 치료에 효과적인 솔루션을 제공합니다. 바이오액티브 창상 드레싱은 감염을 제어하고, 치유 과정을 가속화하고, 누출 위험을 줄이고, 통증과 불편함을 완화하는 데 도움이 됩니다. 키토산, 알긴산염, 케라틴, 하이드로콜로이드, 콜라겐과 같은 재료는 종종 바이오액티브 창상 드레싱의 주요 컴포넌트입니다. 바이오액티브 창상 치료는 선진국과 신흥 시장 모두에서 이러한 제품에 대한 엄청난 수요를 보이는 새롭지만 번창하고 있는 시장입니다.

바이오액티브 창상 드레싱 시장 전체에서는 항균성 창상 드레싱에 대한 수요가 현재 가장 높은데, 그 이유는 감염과 싸우고 치유 과정을 가속화하는 능력 때문입니다. 항균 드레싱은 화상 치료에 널리 사용됩니다. 가장 일반적인 항균 드레싱은 은 코팅 드레싱과 카덱소머 드레싱입니다. 활성탄과 폴리헥사메틸렌 비구아니드 염산염을 포함한 새로운 항균 제품은 은 알레르기 환자에게도 적합합니다. 따라서 항균 드레싱의 채택이 증가하여 전체 바이오액티브 창상 드레싱 시장을 주도할 것입니다. 이 외에도 고령화 사회의 발전과 당뇨병성 궤양의 증가도 시장 성장 촉진요인으로 꼽힙니다. 음압 창상 드레싱, 반투과성, 투과성 폼 드레싱이 바이오액티브 창상 치료 제품의 주요 경쟁 제품입니다.

목차

제1장 서문

  • 리포트 내용
    • 보고서의 목적
    • 대상 독자
    • 주요 제공 상품
  • 시장 세분화
  • 조사 방법

제2장 주요 요약

제3장 바이오액티브 창상 치료 시장 : 경쟁 분석

  • 주요 벤더의 시장 포지셔닝
  • 벤더가 채택하는 전략
  • 주요 산업 전략
  • Tier 분석 : 2022 vs 2031

제4장 바이오액티브 창상 치료 시장 : 거시적 분석과 시장 역학

  • 서론
  • 세계의 바이오액티브 창상 치료 시장 금액 2021-2031
  • 시장 역학
    • 시장 촉진요인
    • 시장 억제요인
    • 주요 과제
    • 주요 기회
  • 촉진요인과 억제요인의 영향 분석
  • 시소 분석

제5장 바이오액티브 창상 치료 시장 : 제품별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 바이오엔지니어링 피부 대체품
    • 콜라겐 기반 드레싱
    • 항균성 드레싱
    • 알긴산염
    • 하이드로콜로이드

제6장 바이오액티브 창상 치료 시장 : 용도별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 욕창
    • 당뇨병성 족궤양
    • 정맥성 하지궤양
    • 화상
    • 수술창

제7장 바이오액티브 창상 치료 시장 : 최종사용자별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 병원·클리닉
    • 외래 수술 센터
    • 기타

제8장 북미의 바이오액티브 창상 치료 시장 2021-2031

  • 시장 개요
  • 바이오액티브 창상 치료 시장 : 제품별 2021-2031
  • 바이오액티브 창상 치료 시장 : 용도별 2021-2031
  • 바이오액티브 창상 치료 시장 : 최종사용자별 2021-2031
  • 바이오액티브 창상 치료 시장 : 지역별 2021-2031
    • 북미
      • 미국
      • 캐나다
      • 기타 북미 지역

제9장 영국과 유럽연합의 바이오액티브 창상 치료 시장 2021-2031

  • 시장 개요
  • 바이오액티브 창상 치료 시장 : 제품별 2021-2031
  • 바이오액티브 창상 치료 시장 : 용도별 2021-2031
  • 바이오액티브 창상 치료 시장 : 최종사용자별 2021-2031
  • 바이오액티브 창상 치료 시장 : 지역별 2021-2031
    • 영국과 유럽연합
      • 영국
      • 독일
      • 스페인
      • 이탈리아
      • 프랑스
      • 기타 유럽 지역

제10장 아시아태평양의 바이오액티브 창상 치료 시장 2021-2031

  • 시장 개요
  • 바이오액티브 창상 치료 시장 : 제품별 2021-2031
  • 바이오액티브 창상 치료 시장 : 용도별 2021-2031
  • 바이오액티브 창상 치료 시장 : 최종사용자별 2021-2031
  • 바이오액티브 창상 치료 시장 : 지역별 2021-2031
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양

제11장 라틴아메리카의 바이오액티브 창상 치료 시장 2021-2031

  • 시장 개요
  • 바이오액티브 창상 치료 시장 : 제품별 2021-2031
  • 바이오액티브 창상 치료 시장 : 용도별 2021-2031
  • 바이오액티브 창상 치료 시장 : 최종사용자별 2021-2031
  • 바이오액티브 창상 치료 시장 : 지역별 2021-2031
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 기타 라틴아메리카 지역

제12장 중동 및 아프리카의 바이오액티브 창상 치료 시장 2021-2031

  • 시장 개요
  • 바이오액티브 창상 치료 시장 : 제품별 2021-2031
  • 바이오액티브 창상 치료 시장 : 용도별 2021-2031
  • 바이오액티브 창상 치료 시장 : 최종사용자별 2021-2031
  • 바이오액티브 창상 치료 시장 : 지역별 2021-2031
    • 중동 및 아프리카
      • GCC
      • 아프리카
      • 기타 중동 및 아프리카

제13장 기업 개요

  • Smith+Nephew
  • MiMedx
  • Integra LifeSciences
  • Organogenesis
  • Tissue Regenix Group Plc
  • Coloplast
  • Hartmann plc
  • Covalon Technologies Ltd.
  • ConvaTec
  • ETS Wound Care LLC
KSA 23.07.04

Bioactive Wound Care Market is Expected to Grow at 7.5% by 2031. Conventional wound healing turns out unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. Introduction of bioactive wound care products has efficiently provided solution to treat such critical wounds and injuries. Bioactive wound dressings control infection and hasten healing process, reduce the risk of leakage, alleviate pain and discomfort. Materials such as chitosan, alginates, keratin, hydrocolloids and collagen are often the key constituents of bioactive wound dressings. Bioactive wound care is a new, yet flourishing market, where phenomenal demand for these products is being witnessed across both developed and developing markets.

In the overall bioactive wound dressings market, the demand for antimicrobial wound dressings is currently the highest die to their ability to fight infections thus hasten the healing process. Antimicrobial dressings are being widely used in burn treatment. Come of the most common antimicrobial dressings used are silver-coated dressings and cadexomer dressings. Novel antimicrobial products including activated charcoal and polyhexamethylene biguanide hydrochloride serve better to patients allergic to silver. Hence, growing adoption of antimicrobial dressings will drive the overall bioactive wound dressings market. Some other prominent drivers of this market include augmenting senescent patient pool and high prevalence of diabetic ulcers. Negative pressure wound dressings, semi-permeable, transparentand foam dressings are the chief competitors to bioactive wound care products.

Key players identified for the bioactive wound dressings market include but are not limited to:

  • Smith+Nephew
  • MiMedx
  • Integra LifeSciences
  • Organogenesis
  • Tissue Regenix Group Plc
  • Coloplast
  • Hartmann plc
  • Covalon Technologies Ltd.
  • ConvaTec
  • ETS Wound Care, LLC

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Bioactive Wound Care market is as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Bioactive Wound Care market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Segmentation

Product

  • Bioengineered Skin Substitutes
  • Collagen-based Dressings
  • Antimicrobial Dressings
  • Alginates
  • Hydrocolloids

Application

  • Pressure Ulcers,
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Burn Wounds
  • Surgical Wounds

End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Bioactive Wound Care market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Bioactive Wound Care market?
  • Which is the largest regional market for Bioactive Wound Care market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Bioactive Wound Care market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Bioactive Wound Care market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Bioactive Wound Care Market
  • 2.2. Global Bioactive Wound Care Market, By Product, 2022 (US$ Million)
  • 2.3. Global Bioactive Wound Care Market, By Application, 2022 (US$ Million)
  • 2.4. Global Bioactive Wound Care Market, By End User, 2022 (US$ Million)
  • 2.5. Global Bioactive Wound Care Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Bioactive Wound Care Market: Competitive Analysis

  • 3.1. Market Positioning of Key Bioactive Wound Care Market Vendors
  • 3.2. Strategies Adopted by Bioactive Wound Care Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Bioactive Wound Care Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Bioactive Wound Care Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Bioengineered Skin Substitutes
    • 5.3.2. Collagen-based Dressings
    • 5.3.3. Antimicrobial Dressings
    • 5.3.4. Alginates
    • 5.3.5. Hydrocolloids

6. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Pressure Ulcers,
    • 6.3.2. Diabetic Foot Ulcers
    • 6.3.3. Venous Leg Ulcers
    • 6.3.4. Burn Wounds
    • 6.3.5. Surgical Wounds

7. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others

8. North America Bioactive Wound Care Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
  • 8.3. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
  • 8.4. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
  • 8.5.Bioactive Wound Care Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.1.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.2.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.3.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)

9. UK and European Union Bioactive Wound Care Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
  • 9.3. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
  • 9.4. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
  • 9.5.Bioactive Wound Care Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.1.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.2.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.3.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.4.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.5.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.6.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)

10. Asia Pacific Bioactive Wound Care Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
  • 10.3. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
  • 10.4. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
  • 10.5.Bioactive Wound Care Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.1.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.2.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.3.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.4.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.5.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.6.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)

11. Latin America Bioactive Wound Care Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
  • 11.3. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
  • 11.4. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
  • 11.5.Bioactive Wound Care Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.1.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.2.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.3.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)

12. Middle East and Africa Bioactive Wound Care Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
  • 12.3. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
  • 12.4. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
  • 12.5.Bioactive Wound Care Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.1.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.2.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Bioactive Wound Care Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.3.1. Bioactive Wound Care Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.1. Bioactive Wound Care Market: By End User, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Smith+Nephew
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. MiMedx
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Integra LifeSciences
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Organogenesis
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Tissue Regenix Group Plc
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Coloplast
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Hartmann plc
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Covalon Technologies Ltd.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. ConvaTec
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. ETS Wound Care, LLC
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제